High complete remission rate and durable remissions achieved with rational use of autologous stem-cell transplantation, thalidomide maintenance, and non-myeloablative allogeneic transplantation in patients with multiple myeloma.

Oyan B., Koc Y., Ozdemir E., Kars A., Turker A., Tekuzman G., ...Daha Fazla

Clinical transplantation, cilt.23, ss.839-47, 2009 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 23
• Basım Tarihi: 2009
• Doi Numarası: 10.1111/j.1399-0012.2008.00950.x
• Dergi Adı: Clinical transplantation
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.839-47
• Anahtar Kelimeler: autologous, multiple myeloma, non-myeloablative, thalidomide, transplantation, HIGH-DOSE THERAPY, DEXAMETHASONE, CHEMOTHERAPY, SURVIVAL, MELPHALAN
• Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır